These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 35381591)

  • 1. Subtle Cognitive Deficits Are Associated with Amyloid-β Positivity, but Not Severity of Self-Reported Decline: Results from the CoSCo Study.
    Ryu SY; Hong YJ; Ho S; Jeong JH; Park KH; Kim S; Wang MJ; Choi SH; Yang DW
    Dement Geriatr Cogn Disord; 2022; 51(2):159-167. PubMed ID: 35381591
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impacts of baseline biomarkers on cognitive trajectories in subjective cognitive decline: the CoSCo prospective cohort study.
    Hong YJ; Ho S; Jeong JH; Park KH; Kim S; Wang MJ; Choi SH; Yang DW;
    Alzheimers Res Ther; 2023 Aug; 15(1):132. PubMed ID: 37550761
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tau levels are higher in objective subtle cognitive decline but not subjective memory complaint.
    Thomas KR; Weigand AJ; Edwards LC; Edmonds EC; Bangen KJ; Ortiz G; Walker KS; Bondi MW;
    Alzheimers Res Ther; 2022 Aug; 14(1):114. PubMed ID: 35996158
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma amyloid-beta oligomer is related to subjective cognitive decline and brain amyloid status.
    Kim KY; Park J; Jeong YH; Kim HJ; Lee E; Park JY; Kim E; Kim WJ
    Alzheimers Res Ther; 2022 Nov; 14(1):162. PubMed ID: 36324157
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Informants' Perception of Subjective Cognitive Decline Helps to Discriminate Preclinical Alzheimer's Disease from Normal Aging.
    Valech N; Mollica MA; Olives J; Tort A; Fortea J; Lleo A; Belén SS; Molinuevo JL; Rami L
    J Alzheimers Dis; 2015 Sep; 48 Suppl 1():S87-98. PubMed ID: 26445275
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heterogeneity of Amyloid Binding in Cognitively Impaired Patients Consecutively Recruited from a Memory Clinic: Evaluating the Utility of Quantitative 18F-Flutemetamol PET-CT in Discrimination of Mild Cognitive Impairment from Alzheimer's Disease and Other Dementias.
    Bao YW; Chau ACM; Chiu PK; Shea YF; Kwan JSK; Chan FHW; Mak HK
    J Alzheimers Dis; 2021; 79(2):819-832. PubMed ID: 33361593
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Region-Specific Association of Subjective Cognitive Decline With Tauopathy Independent of Global β-Amyloid Burden.
    Buckley RF; Hanseeuw B; Schultz AP; Vannini P; Aghjayan SL; Properzi MJ; Jackson JD; Mormino EC; Rentz DM; Sperling RA; Johnson KA; Amariglio RE
    JAMA Neurol; 2017 Dec; 74(12):1455-1463. PubMed ID: 28973551
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Symptomatic Clusters Related to Amyloid Positivity in Cognitively Unimpaired Individuals.
    Sannemann L; Bartels C; Brosseron F; Buerger K; Fliessbach K; Freiesleben SD; Frommann I; Glanz W; Heneka MT; Janowitz D; Kilimann I; Kleineidam L; Lammerding D; Laske C; Munk MHJ; Perneczky R; Peters O; Priller J; Rauchmann BS; Rostamzadeh A; Roy-Kluth N; Schild AK; Schneider A; Schneider LS; Spottke A; Spruth EJ; Teipel S; Wagner M; Wiltfang J; Wolfsgruber S; Duezel E; Jessen F;
    J Alzheimers Dis; 2024; 100(1):193-205. PubMed ID: 38848176
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between retinal thickness and β-amyloid brain accumulation in individuals with subjective cognitive decline: Fundació ACE Healthy Brain Initiative.
    Marquié M; Valero S; Castilla-Marti M; Martínez J; Rodríguez-Gómez O; Sanabria Á; Tartari JP; Monté-Rubio GC; Sotolongo-Grau O; Alegret M; Pérez-Cordón A; Roberto N; de Rojas I; Moreno-Grau S; Montrreal L; Hernández I; Rosende-Roca M; Mauleón A; Vargas L; Abdelnour C; Gil S; Esteban-De Antonio E; Espinosa A; Ortega G; Lomeña F; Pavia J; Vivas A; Tejero MÁ; Gómez-Chiari M; Simó R; Ciudin A; Hernández C; Orellana A; Benaque A; Ruiz A; Tárraga L; Boada M;
    Alzheimers Res Ther; 2020 Mar; 12(1):37. PubMed ID: 32234080
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Difference in Amyloid Load Between Single Memory Domain and Multidomain Subjective Cognitive Decline: A Study from the SILCODE.
    Wang X; Bi Q; Lu J; Chan P; Hu X; Su L; Jessen F; Lin H; Han C; Shu N; Liu H; Han Y
    J Alzheimers Dis; 2022; 85(4):1573-1582. PubMed ID: 34958039
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Associations Between the Subjective Cognitive Decline-Questionnaire's Scores, Gray Matter Volume, and Amyloid-β Levels.
    Valech N; Sánchez-Benavides G; Tort-Merino A; Coll-Padrós N; Olives J; León M; Falcon C; Molinuevo JL; Rami L
    J Alzheimers Dis; 2019; 72(4):1287-1302. PubMed ID: 31707366
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subtle executive deficits are associated with higher brain amyloid burden and lower cortical volume in subjective cognitive decline: the FACEHBI cohort.
    Pérez-Cordón A; Monté-Rubio G; Sanabria A; Rodriguez-Gomez O; Valero S; Abdelnour C; Marquié M; Espinosa A; Ortega G; Hernandez I; Rosende-Roca M; Vargas L; Mauleón A; Gil S; Tartari JP; Lomeña F; Campos F; Vivas A; Gomez-Chiari M; Benaque A; Ruiz A; Tárraga L; Boada M; Alegret M;
    Sci Rep; 2020 Oct; 10(1):17721. PubMed ID: 33082443
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amyloid-β Positivity Predicts Cognitive Decline but Cognition Predicts Progression to Amyloid-β Positivity.
    Elman JA; Panizzon MS; Gustavson DE; Franz CE; Sanderson-Cimino ME; Lyons MJ; Kremen WS;
    Biol Psychiatry; 2020 May; 87(9):819-828. PubMed ID: 32067693
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Which features of subjective cognitive decline are related to amyloid pathology? Findings from the DELCODE study.
    Miebach L; Wolfsgruber S; Polcher A; Peters O; Menne F; Luther K; Incesoy E; Priller J; Spruth E; Altenstein S; Buerger K; Catak C; Janowitz D; Perneczky R; Utecht J; Laske C; Buchmann M; Schneider A; Fliessbach K; Kalbhen P; Heneka MT; Brosseron F; Spottke A; Roy N; Teipel SJ; Kilimann I; Wiltfang J; Bartels C; Düzel E; Dobisch L; Metzger C; Meiberth D; Ramirez A; Jessen F; Wagner M
    Alzheimers Res Ther; 2019 Jul; 11(1):66. PubMed ID: 31366409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brain Functional Alterations and Association with Cognition in People with Preclinical Subjective Cognitive Decline and Objective Subtle Cognitive Difficulties.
    Ren S; Li J; Huang L; Huang Q; Chen K; Hu J; Jessen F; Hu X; Jiang D; Zhu L; Wang X; Guan Y; Hua F; Guo Q; Xie F
    Neuroscience; 2023 Mar; 513():137-144. PubMed ID: 36634906
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Influence of Amyloid Burden on Cognitive Decline over 2 years in Older Adults with Subjective Cognitive Decline: A Prospective Cohort Study.
    Hong YJ; Park JW; Lee SB; Kim SH; Kim Y; Ryu DW; Park KW; Yang DW
    Dement Geriatr Cogn Disord; 2021; 50(5):437-445. PubMed ID: 34736258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design and first baseline data of the DZNE multicenter observational study on predementia Alzheimer's disease (DELCODE).
    Jessen F; Spottke A; Boecker H; Brosseron F; Buerger K; Catak C; Fliessbach K; Franke C; Fuentes M; Heneka MT; Janowitz D; Kilimann I; Laske C; Menne F; Nestor P; Peters O; Priller J; Pross V; Ramirez A; Schneider A; Speck O; Spruth EJ; Teipel S; Vukovich R; Westerteicher C; Wiltfang J; Wolfsgruber S; Wagner M; Düzel E
    Alzheimers Res Ther; 2018 Feb; 10(1):15. PubMed ID: 29415768
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Can we predict amyloid deposition by objective cognition and regional cerebral blood flow in patients with subjective cognitive decline?
    Funaki K; Nakajima S; Noda Y; Wake T; Ito D; Yamagata B; Yoshizaki T; Kameyama M; Nakahara T; Murakami K; Jinzaki M; Mimura M; Tabuchi H
    Psychogeriatrics; 2019 Jul; 19(4):325-332. PubMed ID: 30688000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Executive and Language Subjective Cognitive Decline Complaints Discriminate Preclinical Alzheimer's Disease from Normal Aging.
    Valech N; Tort-Merino A; Coll-Padrós N; Olives J; León M; Rami L; Molinuevo JL
    J Alzheimers Dis; 2018; 61(2):689-703. PubMed ID: 29254090
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Using Neuropsychological Process Scores to Identify Subtle Cognitive Decline and Predict Progression to Mild Cognitive Impairment.
    Thomas KR; Edmonds EC; Eppig J; Salmon DP; Bondi MW;
    J Alzheimers Dis; 2018; 64(1):195-204. PubMed ID: 29865077
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.